Glow LifeTech Secures Canadian Processing Facility; Begins Build-out to Produce Next-Generation Cannabis Ingredients
News
Glow LifeTech Reports on Additional Research Results on ArtemiC™ and Positive Implications for COVID-19 Variants
Glow LifeTech Announces Successful First Commercial Production of ArtemiC™ for Global Distributor and a Second Production Scaled to Meet Growing Global Demand
Glow LifeTech Submits Application to Health Canada for Natural Health Product Following Successful COVID-19 Phase II Clinical Trial
Glow LifeTech to Commence Trading on the CSE on March 15, 2021 Under the Symbol “GLOW”
Glow LifeTech Corp. Announces Completion of Business Combination
Relay Medical Reports Glow LifeTech Secures Exclusive North American Rights to ArtemiC™ Following Successful COVID-19 Phase II Clinical Trial
Relay Medical Announces Subsidiary Glow LifeTech has Secured Exclusive Rights for Award Winning Swiss Technology